Thu, October 19, 2023
Wed, October 18, 2023
Tue, October 17, 2023
Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023

Rick Bienkowski Maintained (BEAM) at Buy with Decreased Target to $32 on, Oct 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-32-on-oct-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Rick Bienkowski of Cantor Fitzgerald, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Decreased Target from $56 to $32 on, Oct 17th, 2023.

Rick has made no other calls on BEAM in the last 4 months.



There are 3 other peers that have a rating on BEAM. Out of the 3 peers that are also analyzing BEAM, 2 agree with Rick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Richard Law of "Credit Suisse" Maintained at Hold with Increased Target to $47 on, Wednesday, August 9th, 2023


This is the rating of the analyst that currently disagrees with Rick


  • Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Decreased Target to $56 on, Wednesday, August 9th, 2023

Publication Contributing Sources